Sphera Funds Management »

Vor Biopharma shares owned by Sphera Funds Management

Quarter-by-quarter ownership of Vor Biopharma (VOR) shares owned by Sphera Funds Management from 13F filings

Historical chart of Sphera Funds Management investment in Vor Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Vor Biopharma held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vor Biopharma by Sphera Funds Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.4M 410k 13.08

More positions owned by Sphera Funds Management

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Biogen Idec (BIIB)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)
NOVA MEASURING Instruments L (NVMI)
Ultragenyx Pharmaceutical (RARE)
Tower Semiconductor Shs New (TSEM)
Cogent Biosciences (COGT)
Astrazeneca Sponsored Adr
Praxis Precision Medicines I Com New Call Option (PRAX)
Sanofi Sa Sponsored Adr (SNY)
Eli Lilly & Co. (LLY)
Amicus Therapeutics (FOLD)
Immatics SHS (IMTX)
BioMarin Pharmaceutical (BMRN)

View all positions for Sphera Funds Management

Top funds holding Vor Biopharma

RA Capital Management
VR Adviser
Dr. Jeffrey R. Jay, M.D.
Susquehanna International
Caligan Partners
Vanguard Group
Shay Capital
Sphera Funds Management
Fcpm Iii Services B.v.
Laurion Capital Management
UBS Group
FMR
Geode Capital Management
Goldman Sachs Group
Jane Street

View all funds holding Vor Biopharma